NAD Study 1

NAD+ Study 1

We are seeking 16 participants for the next round of testing for a new formulation for NAD+ support. This will be a 3-week study and the product will be packaged in capsules. They will be provided with NAD+ product and instructed to take in the morning with a large glass of water (or other beverage) following a five day dosing and two day off schedule.  They will be asked to take the questionnaire in the evening of their first dose, after using for 5 days, after 2 weeks, and after 3 weeks.

Participation Requirements:

  • To not begin taking any new supplements while testing this product and continue taking any supplements they are currently using regularly. 

  • Willingness to complete questionnaires, records, and diaries associated with the study.

Exclusion Criteria:

  • Women who are pregnant, breastfeeding, or planning to become pregnant during the trial

  • Known food intolerances/allergy to any ingredients in the product

  • Having any of the following conditions: Psychiatric conditions, neurologic disorders, high blood pressure, heart conditions, endocrine disorders, cancer

  • Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines

  • On immunosuppressive therapy

  • Vegan, since we can’t guarantee that all ingredients will be vegan for this project.

This beta test has been completed

Your Cart

Loading your cart

Your cart is empty

Continue Shopping

Sign In